Profil
Pradip K. Banerjee ist Chairman und Chief Executive Officer von ImmuMed Technologies, Inc. sowie Chairman und Chief Executive Officer von Xybion Corp. und Chief Technology Officer von Hindalco Industries Ltd. In der Vergangenheit war Dr. Banerjee Chairman der Essential Group, Inc. und President & Chief Executive Officer des University City Science Center.
Aktive Positionen von Pradip Banerjee
| Unternehmen | Position | Beginn |
|---|---|---|
| XYBN DIGI | Vorstandsvorsitzender | 15.11.2021 |
ImmuMed Technologies, Inc.
ImmuMed Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops polyclonal antibodies for adjuvant therapies | Vorstandsvorsitzender | - |
Xybion Corp.
Xybion Corp. Packaged SoftwareTechnology Services Operates as a SaaS company that helps enterprise life sciences organizations accelerate new drug development | Vorstandsvorsitzender | 01.02.2008 |
Ehemalige bekannte Positionen von Pradip Banerjee
| Unternehmen | Position | Ende |
|---|---|---|
University City Science Center
University City Science Center Investment Trusts/Mutual FundsMiscellaneous Provides physical space, resources and other support to the community | Vorstandsvorsitzender | 01.01.2007 |
Essential Group, Inc.
Essential Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and contract research services for pharmaceutical and biotech companies | Vorsitzender | 14.12.2006 |
Ausbildung von Pradip Banerjee
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Essential Group, Inc.
Essential Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and contract research services for pharmaceutical and biotech companies | Commercial Services |
ImmuMed Technologies, Inc.
ImmuMed Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops polyclonal antibodies for adjuvant therapies | Health Technology |
Xybion Corp.
Xybion Corp. Packaged SoftwareTechnology Services Operates as a SaaS company that helps enterprise life sciences organizations accelerate new drug development | Technology Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University City Science Center
University City Science Center Investment Trusts/Mutual FundsMiscellaneous Provides physical space, resources and other support to the community | Miscellaneous |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xybion Digital, Inc.
Xybion Digital, Inc. Packaged SoftwareTechnology Services Develops SaaS cloud platform for drug research and development | Technology Services |
















